These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29349890)

  • 1. Case report: Cytochrome P450 implications for comorbid ADHD and OCD pharmacotherapy.
    Hogan MK; Rao NP
    J Child Adolesc Psychiatr Nurs; 2017 Aug; 30(3):126-132. PubMed ID: 29349890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Picking Successfully Treated With Atomoxetine in Comorbid Skin Picking and Attention-Deficit/Hyperactivity Disorder: A Case Report.
    Yurteri N; Sarıgedik E
    Clin Neuropharmacol; 2020; 43(4):114-115. PubMed ID: 32541332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
    Brown JT; Bishop JR; Sangkuhl K; Nurmi EL; Mueller DJ; Dinh JC; Gaedigk A; Klein TE; Caudle KE; McCracken JT; de Leon J; Leeder JS
    Clin Pharmacol Ther; 2019 Jul; 106(1):94-102. PubMed ID: 30801677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine pharmacogenetics: associations with pharmacokinetics, treatment response and tolerability.
    Brown JT; Bishop JR
    Pharmacogenomics; 2015; 16(13):1513-20. PubMed ID: 26314574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation.
    Grassi G; Micheli L; Di Cesare Mannelli L; Compagno E; Righi L; Ghelardini C; Pallanti S
    J Psychiatr Res; 2016 Dec; 83():240-248. PubMed ID: 27665536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delusional infestation in the treatment of ADHD with atomoxetine.
    Howes CF; Sharp C
    Drug Ther Bull; 2019 Jun; 57(6):93-95. PubMed ID: 31126905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atomoxetine for treatment of children and adolescents with ADHD].
    Resen K; Pagsberg AK; Jörgens G
    Ugeskr Laeger; 2014 Mar; 176(10A):. PubMed ID: 25350704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Hesitancy Associated With Atomoxetine.
    Gandhi R; Narang P; Lippmann S
    Prim Care Companion CNS Disord; 2017 Sep; 19(5):. PubMed ID: 28930379
    [No Abstract]   [Full Text] [Related]  

  • 9. Atomoxetine-related Takotsubo Cardiomyopathy.
    Naguy A; Al-Mutairi H; Al-Tajali A
    J Psychiatr Pract; 2016 May; 22(3):232-3. PubMed ID: 27123802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial.
    Shaywitz S; Shaywitz B; Wietecha L; Wigal S; McBurnett K; Williams D; Kronenberger WG; Hooper SR
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):19-28. PubMed ID: 27410907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
    Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
    CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.
    Fredriksen M; Peleikis DE
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):23-31. PubMed ID: 26404187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Frequency of Encopresis in a Child Diagnosed With Attention Deficit/Hyperactivity Disorder and Encopresis After Atomoxetine Use: A Case Report.
    Yektaş Ç; Cansiz MA; Tufan AE
    Clin Neuropharmacol; 2016; 39(4):212-3. PubMed ID: 27332628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Atomoxetin Use in the Treatment of Attention-Deficit/Hyperactivity Disorder on the Symptoms of Restless Legs Syndrome: A Case Report.
    Baykal S; Karakurt MN
    Clin Neuropharmacol; 2017; 40(2):93-94. PubMed ID: 28195837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
    Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atomoxetine Treatment For Encopresis In A Child With Attention Deficit Hyperactivity Disorder].
    Bozkurt H; Şahin S
    Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27482753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine in the Treatment of Adolescent With Trichotillomania and Attention-Deficit/Hyperactivity Disorder.
    Türkoğlu S; Çetin FH
    Clin Neuropharmacol; 2018; 41(2):84-85. PubMed ID: 29533364
    [No Abstract]   [Full Text] [Related]  

  • 18. Atomoxetine Use in Attention-Deficit/Hyperactivity Disorder and Comorbid Tic Disorder in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.
    Demirkaya SK; Demirkaya M; Yusufoğlu C; Akın E
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):104-105. PubMed ID: 27315236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
    Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
    Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal dosing of Strattera (atomoxetine) for ADHD patients.
    Clemow DB
    Postgrad Med; 2014 Sep; 126(5):196-8. PubMed ID: 25420287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.